Novavax
NVAX
#4993
Rank
โ‚น120.61 B
Marketcap
โ‚น752.96
Share price
-3.55%
Change (1 day)
126.65%
Change (1 year)

P/E ratio for Novavax (NVAX)

P/E ratio as of February 2025 (TTM): -1.20

According to Novavax's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.19958. At the end of 2022 the company had a P/E ratio of -1.24.

P/E ratio history for Novavax from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-1.24-79.84%
2021-6.14-62.59%
2020-16.42239.61%
2019-0.7019-80.73%
2018-3.6485.12%
2017-1.9760.9%
2016-1.22-91.4%
2015-14.2-13.67%
2014-16.5-0.27%
2013-16.592.25%
2012-8.5915.91%
2011-7.413.7%
2010-7.1526.28%
2009-5.6658.71%
2008-3.57-38.96%
2007-5.84-44.43%
2006-10.5-29%
2005-14.8222.5%
2004-4.59-54.85%
2003-10.2259.84%
2002-2.83-91.38%
2001-32.8

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-4.52 276.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-14.5 1,106.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.9329-22.23%๐Ÿ‡บ๐Ÿ‡ธ USA
-6.38 431.85%๐Ÿ‡บ๐Ÿ‡ธ USA
35.7-3,077.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
14.3-1,292.61%๐Ÿ‡บ๐Ÿ‡ธ USA
28.0-2,431.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-2.03 68.82%๐Ÿ‡บ๐Ÿ‡ธ USA
10.1-940.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
-10.3 761.94%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.